[1]
S. Tereszkiewicz, “The influence of proteasome inhibitor on the expression of cardiomyocytes damage markers after incubation with doxorubicin”, Curr. Issues Pharm. Med. Sci., vol. 27, no. 2, pp. 88–91, Nov. 2014, doi: 10.2478/cipms-2014-0020.